The Local Efficacy of I-131 for F-18 FDG PET Positive Lesions in Patients With Recurrent or Metastatic Thyroid Carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Local Efficacy of I-131 for F-18 FDG PET Positive Lesions in Patients With Recurrent or Metastatic Thyroid Carcinomas

Published:2011-02 Issue:2 Volume:36 Page:113-117
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Yoshio Kotaro,Sato Shuhei,Okumura Yoshihiro,Katsui Kuniaki,Takemoto Mitsuhiro,Suzuki Etsuji,Katayama Norihisa,Kaji Mitsumasa,Kanazawa Susumu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference19 articles.

1. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer.;Mazzaferri;J Clin Endocrinol Metab,2001

2. Thyroid remnant 131-I ablation for papillary and follicular thyroid carcinoma.;Mazzaferri;Thyroid,1997

3. Papillary thyroid carcinoma. Etiology, assessment, and therapy.;Ain;Endocrinol Metab Clin North Am,1995

4. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.;Shoup;J Am Coll Surg,2003

5. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.;Dinneen;J Clin Endocrinol Metab,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of [18F]FDG PET/CT in avoiding overtreatment of 131l avidity pulmonary metastasis of differentiated thyroid cancer;Endokrynologia Polska;2023-07-21

2. Theranostics – present and future;Bio-Algorithms and Med-Systems;2021-12-01

3. Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma;Annals of Nuclear Medicine;2021-08-11

4. Clinical Perspectives of Theranostics;Molecules;2021-04-13

5. FDG PET Predicts the Effects of 131I and Prognosis for Patients with Bone Metastases from Differentiated Thyroid Carcinoma;Cancer Management and Research;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3